MCPAP for Moms. In this Issue: Leadership: Promoting Maternal Mental Health During and After Pregnancy.

Similar documents
What About the Siblings?

Promoting Maternal Mental Health During and After Pregnancy

In this Issue: Non-Suicidal Self-Injury: The Facts About Cutting. Leadership:

Perinatal Depression: Current Management Issues

Matrix Framework of PERINATAL DEPRESSION and RELATED DISORDERS

Postpartum Depression Screening

CENTER OF EXCELLENCE MATERNAL AND CHILD MENTAL HEALTH (MCMH)

Identifying and Treating Anxiety Disorders

Specialist Perinatal Mental Health Service (SPMHS)

Peripartum Depression:

Objectives. Mother-Infant Communication. Depression. Disclosures of Potential Conflicts. Why Is Perinatal Mental Health Important?

Structured Guidance for Postpartum Retention in HIV Care

Perinatal Mood Disorders: An Interdisciplinary Training Video. Facilitator s Guide, Pre-test and Post-test

Baby Pediatric Symptom Checklist (BPSC) Scoring Guide

How Psychiatric Access Programs are Bridging the Behavioral Health Divide and Filling the Psychiatric Shortage

Perinatal Depression: What We Know

Addressing Perinatal Depression in the Outpatient Obstetric Setting

PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE

Social support and depression: An evaluation of MotherWoman peer support groups for mothers with postpartum depression

Behavioral Health. Behavioral Health. Prescribing Guidelines

PERINATAL MENTAL HEALTH PATHWAY FOR BUCKINGHAMSHIRE

Reducing Maternal Mortality & Morbidity Surveillance & Action

Policy Statement January 2009

Goldie Watkins-Bryant, MPH Central Harlem Healthy Start Director

Healthy Start, Healthy Scotland

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Day-to-Day Activities

Focalin compared to concerta

Perinatal Mental Health Certification Blueprint (2018)

ORAL HEALTH CARE DURING PREGNANCY: A NATIONAL CONSENSUS STATEMENT

WELLNESS CENTERS: A Coordinated Model to Support Students Physical & Emotional Health and Well-being in TUHSD High Schools

11 th Annual Pacer Symposium on Children s Mental Health

Taking Care: Child and Youth Mental Health TREATMENT OPTIONS

Criminalization of Substance Use Among Pregnant Women in Tribal Communities. March 22, 2018

Integration Model: Services for HIV Infected Women and their Infants

Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services

Perinatal Mental Health

The Aboriginal Maternal and Infant Health Service: a decade of achievement in the health of women and babies in NSW

Mental Health Screening in Primary Care Pediatrics

The Royal College of Psychiatrists in Scotland A PERINATAL AND INFANT MENTAL HEALTH ACTION PLAN FOR SCOTLAND

SAN FRANCISCO PERINATAL & NEWBORN PERTUSSIS AND FLU COLLABORATIVE

Overview of the Growing Together Toolkit

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

in Illinois Illinois Department of Public Health Perinatal Rapid Testing Initiative for Illinois (PRTII2)

Antenatal and Postnatal Mental Health - Guideline Update

The National Healthy Mothers, Healthy Babies Coalition

Page: 1 of 5. Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (12).

Thursday, May 5, :00 a.m. Eastern

Maternal Depression. Screening For Postpartum Depression at Infant Well- Visits: Screening, Follow-up and Referral

Preconception Health in North Carolina. February 13, 2012 Perinatal Health Committee Child Fatality Task Force

Addressing the Opioid Crisis Policy Recommendations

Response to the Language Equality and Acquisition for Deaf Kids (LEAD-K) Task Force Report

Ask The Shrink: ADHD

Perinatal Depression Treatment and prevention. Dr. Maldonado

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

Moving Beyond Cooperation: Engaging Families in Health Care Organizations and Practices Thursday, May 25, Noon Central

This report examines the demographics and risk factors associated with maternal depression. It looks at the current

Perinatal Psychiatry Program

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

WOMEN S HEALTH CLINIC STRATEGIC PLAN

Preterm Birth Initiative Community Advisory Board Application

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change?

PERINATAL PALLIATIVE CARE SUPPORTING FAMILIES AS THEY PREPARE TO WELCOME THEIR BABY AND TO SAY GOOD-BYE

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Michigan NAS Policy Academy Team

What Can MIHP Providers Do?

Depression During and After Pregnancy

MCPAP Clinical Conversations: Attention Deficit/Hyperactivity Disorder (ADHD) Update: Rollout of New MCPAP ADHD Algorithm

Loving Support Award of Excellence Gold Award Application Instructions

Methylphenidate Dexmethylphenidate

Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (14).

CEDAW Shadow / Alternative report: Review on Women s Right in Mental Health

EI Leadership April 24, 2018

5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

Maternal Emotional Wellness Resource Guide

Postpartum Depression

5/12/11. Educational Objectives. Goals

Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH

MCPAP Clinical Conversations: Depression Update: Rollout of New MCPAP Depression Algorithm

Date January 20, Contact Information

California. Maternal and Child Health Block Grant 2018

The State of Pregnancy-Related Depression Efforts in Colorado

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.

Clinical Practice Guideline for Preventive Health Care - Pediatrics

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Postpartum Depression and Marital Relationship

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Maternal Depression: Prevalence, Implications, Diagnosis, and Current Treatment Options

New Jersey Department of Children and Families Policy Manual. Date: Chapter: A Health Services Subchapter: 1 Health Services

Implementing Postpartum Depression Screening During Infant Well Child Checks:

The Perinatal Mental Health Project (PMHP)

AAP Immunization Initiatives JILL HERNANDEZ, MPH

Depression During and After Pregnancy

The Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy

Trust Headquarters, St George s Hospital Stafford

Methylphenidate Dexmethylphenidate

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN

Transcription:

July 2014 NEWS MCPAP for Moms Promoting Maternal Mental Health During and After Pregnancy By Elaine Gottlieb In this Issue: Primary Care Triple P Enables you to Help Parents 4 Lily*, a financial professional and mother in her 30s, came to Cambridge pediatrician Dr. Michael Yogman s office for her baby s two-month well-child visit. To the experienced office staff she seemed like any new mother. But the Edinburgh Postnatal Depression Scale (EPDS) revealed that she had symptoms of depression. In an in-depth interview with Dr. Yogman and the practice social worker, Lily confided that she had a history of depression and anxiety, had very specific suicide plans, and contemplated throwing the baby, who was very colicky, out the window. She was immediately sent to a Boston hospital emergency department for treatment of postpartum depression (PPD). She received inpatient treatment and outpatient psychotherapy. At the baby s four-month visit, he was smiling and happy, and Lily and her husband described the intervention as life-saving. Continued on page 2 Black Box Warning for ADHD Meds New Policy on Care Coordination Leadership: John Straus, MD Founding Director Barry Sarvet, MD Medical Director 5 6 Marcy Ravech, MSW Director 1000 Washington St., Suite 310 Boston, MA 02118 E-mail: mcpap@valueoptions.com www.mcpap.org

2 Moms Continued from page 1 Postpartum depression is a hidden epidemic: it s under-identified and vastly undertreated. If we treat maternal depression, a major source of toxic stress, we could decrease infant emergency room admissions and improve outcomes later in life, says Dr. Yogman, who routinely screens mothers (and sometimes fathers and other caregivers) at one, two, four, and six months during the postpartum year. PPD affects nearly 20 percent of mothers: in Massachusetts, with 72,835 births in 2010, that translates to 9-14,000 mothers with depression. In July, MCPAP is launching MCPAP for Moms, which will provide perinatal providers with the information and assistance they need to screen, identify and refer mothers for treatment. While the program s focus is on depression occurring in pregnant and postpartum women, it will also address depression in fathers and adoptive parents. Postpartum depression is associated with attachment difficulties and an increased risk of anxiety and/or disruptive disorders among children of depressed mothers. It is associated with changes in the children s social, cognitive, and psychological development. PPD also increases the risk of the father or partner becoming depressed, says Nancy Byatt, DO, MBA, FAPM, MCPAP for Moms Medical Director and assistant professor of Psychiatry and Obstetrics & Gynecology, UMass Memorial Medical Center/ UMass Medical School. MCPAP for Moms will address the barriers that have prevented effective PPD diagnosis and treatment: stigma, lack of provider training, lack of referral networks and resources, and limited access to mental health treatment. Just as we have helped pediatric providers address children s behavioral health, we will support them in addressing parents mental health in this very crucial period, says John Straus, MD, MCPAP Founding Director. A Focus on Prevention One major study screened 10,000 women for PPD and found that one-third of women with PPD developed depression during pregnancy. Overall, the greatest predictor for PPD is a prior history of depression. MCPAP for Moms goal is to have providers conduct two prenatal and four postpartum depression screenings. Two-thirds of women with postpartum depression could be identified before the birth of their child, and the condition could be addressed before it has negative consequences, says Dr. Straus. Providers should also monitor the mental health of fathers and other caregivers as well as adoptive parents. A Comprehensive Program Directed by UMass Memorial Medical Center, MCPAP for Moms features three core components: Training and toolkits for obstetric and pediatric providers featuring evidence-based guidelines for depression screening, triage and referrals, risks and benefits of psychotropic medications, and discussion of screening results and treatment options. The training materials, toolkit and additional resources will also be available on our website at www.mcpapformoms.org. Real-time psychiatric consultation and care coordination for providers serving pregnant and postpartum women and their babies. Linkages with community-based resources including mental health care, support groups, and other resources to support the wellness and mental health of pregnant and postpartum women. A database of statewide PPD resources is being developed by the Massachusetts School of Professional Psychology Interface Referral Service. Information about community and psychosocial supports will be available at the MCPAP for Moms website: www.mcpapformoms.org. Continued on page 3

3 Moms Continued from page 2 MCPAP for Moms is partnering with MotherWoman, an organization for mothers based in Hadley, MA, to develop perinatal support coalitions in six communities that will ensure that pregnant and postpartum women with depression receive the care and treatment they need. Based on MotherWoman s successful Community-Based Perinatal Support Model, the coalitions will be guided by a leadership team and include a perinatal support group for mothers at risk for or experiencing PPD. MCPAP for Moms eventual goal is to have support groups available at every birthing hospital. 20 % of mothers are affected with postpartum depression We want to create an environment where women feel comfortable discussing depression with providers without fear of being stigmatized or losing custody of their child and providers are empowered to discuss the condition with mothers, screen, and make referrals to appropriate resources. Creating those resources is a key part of the program, says Dr. Byatt. How the Program Will Work MCPAP for Moms will serve the following providers: Obstetric providers obstetricians/ gynecologists, midwives, labor and delivery nurses, and family physicians Primary care providers (internists, family practitioners) of mothers who are post-partum Front-line psychiatric and mental health providers, such as psychiatrists, psychiatric nurses, psychologists and social workers Because pediatric providers do not serve moms directly, their role is one of screening and referral. MCPAP for Moms will offer a pediatric screening algorithm that includes screening for PPD. Unless it is an emergency, pediatricians should refer moms with a positive screen back to their obstetric providers or primary care physicians, who can obtain assistance directly from MCPAP for Moms. Pediatricians can also call their regular MCPAP Hubs for assistance or consultation with the screening tool, results of screening, or other concerns. If appropriate, the MCPAP Hub will facilitate the connection with MCPAP for Moms. MCPAP for Moms services include: Psychiatric consultation MCPAP for Moms perinatal psychiatrists will provide real-time phone consultation regarding diagnostic support, medication options (when indicated), psychotherapy and community support needs, treatment planning, and medication concerns during preconception, pregnancy, and lactation. MCPAP for Moms psychiatrists are also available for in-person patient assessment when needed. Care coordination Care coordinators will work with providers to arrange services for patients. Continued on page 4 Having a program that trains providers and provides resources and referrals is critical; it will make providers more comfortable jumping into an area they aren t experienced in, says Dr. Yogman.

4 Moms Continued from page 3 Effective Treatment, Improved Outcomes It is essential to maximize non-medication treatment options. Evidence-based psychotherapy treatments for depression include and cognitive-behavioral therapy (CBT) and interpersonal psychotherapy (IPT). We will also encourage referrals to support groups. Depending on the severity of the depression, medication may also be indicated. MCPAP for Moms psychiatrists will assist providers in assessing whether medication is indicated and which medication may be best when a woman is pregnant or lactating. For more information on MCPAP for Moms visit www.mcpapformoms.org Pediatricians enrolled in MCPAP should expect to receive a toolkit of information over the summer. You can also contact your Regional Hub. Obstetric providers, family practitioners, adult primary care providers, and psychiatrists can contact MCPAP for Moms at 855-Mom-MCPAP as of July 1, 2014. Engaging fathers in treatment is also beneficial. The best outcome for babies is treating the dyad and the triad. Treatment makes all the difference in the world, says Dr. Yogman. *Name changed to protect patient confidentiality. Are you struggling to help parents of your pre-school age patients with difficult behaviors? MCPAP is recruiting providers for our next Primary Care Triple P Positive Parenting Program training. The two-day training will take place in early October, followed by a one-day pre-accreditation workshop and a half-day accreditation date in November. MCPAP is prioritizing behavioral health clinicians or medical providers working within pediatric practices for participation in this free initiative that provides parents with increased confidence and parenting skills. Funded by a Race to the Top grant through the Department of Early Education and Childcare and the Department of Mental Health, our goal is to increase access to services for young children with behavior challenges and their parents. For more information or to enroll please contact Marcy Ravech at MCPAP 617-350-1978 or marcy.ravech@valueoptions.com.

5 Recent Black Box Warning for ADHD Medications By Hisla Bates, MD The US Food and Drug Administration (FDA) posted a new black box warning on December 2013 that suggests stimulant medication methylphenidate (Ritalin) and its derivatives, used to treat ADHD, may cause prolonged and painful erections lasting several hours, a condition known as priapism. Priapism is a condition where blood accumulates in the penis, and urgent medical intervention is needed to relieve the blockage. Although priapism is rare, it has serious consequences if it goes untreated, causing permanent damage to the penis. The list of medications that are implicated are Concerta, Daytrana, Focalin/Focalin XR, Metadate CD/Metadate ER, Methylin/ Methylin ER, Quillivant XR, Ritalin/Ritalin LA/Ritalin SR. The drug labels and patient Medication Guides have been updated with this information. Other non-stimulant medications such as Strattera (atomoxetine) have been implicated as well. Strattera (atomoxetine), has been associated with priapism in children, teens, and adults. According to the FDA, priapism appears to be more common in patients taking atomoxetine than in those taking methylphenidate products; however, because of limitations in available information, the FDA does not know how often priapism occurs in patients taking either type of product. There were four cases noted; the median age was 12.5 years, and the ages ranged from 8 to 33. Of the four cases identified, two needed surgical intervention, one required needle aspiration and another required a penile shunt. There seemed to be little correlation with dosage. Events occurred when drugs were being increased, decreased and even discontinued (including drug holidays). When prescribing stimulants (methylphenaldate) including some non-stimulant (atomoxetine) medications for ADHD, it is important to warn caregivers and patients of priapism, a rare but serious side effect. Parents and children should know that any frequent or persistent penile erections should be reported immediately to a medical professional. References www.fda.gov/drugs/drugsafety/ucm375796.htm www.fda.gov/drugs/drugsafety/drugsafetypodcasts/ucm379162.htm www.fda.gov/safety/medwatch/safetyinformation/ucm381078.htm Advice from the American Academy of Pediatrics (AAP) ADHD: Clinical Practice Guidelines The American Academy of Pediatrics (AAP) clinical practice guidelines offer some key action statements that help primary care clinicians evaluate, diagnose, treat, and monitor children and adolescents with ADHD. One such action statement is: Conduct a face-to-face followup visit on a monthly basis during initial stage, and then follow up with subsequent visits every three months in the first year of treatment. Subsequent visits occur at least twice a year. Following AAP guidelines will give a practice a 100 percent score on the HEDIS ADHD measure that many health plans use!

New Policy Statement on Care Coordination and Free Access to an Online Curriculum 6 Care coordination is an essential element of a transformed American health care delivery system that emphasizes optimal quality and cost outcomes, addresses family-centered care, and calls for partnership across various settings and communities. The policy statement, Patient- and Family-Centered Care Coordination: A Framework for Integrating Care for Children and Youth Across Multiple Systems, appeared in the May issue of Pediatrics. This policy, co-authored by the Council on Children with Disabilities (COCWD) and the Medical Home Implementation Project Advisory Committee, specifically outlines the essential partnerships that are critical to this framework. Implementation of this framework aims for lower health care costs, less fragmented care, and an improved experience for children and families. The policy provides practical application of care coordination integration in practices and communities and is intended to be broadly focused, realizing that every community has different needs, assets, and service gaps based on location, population, and cultural factors. An accompanying article in AAP News, Beyond the Medical Home: Coordinating Care for Children, also highlights the importance of this policy. To further augment and facilitate the application of the recommendations within this policy statement, the online Pediatric Care Coordination Curriculum provides content which can be adapted to the needs of any entity (e.g., a single practice, a network of practices, parent and family organizations, or a state-wide organization such as Title V MCH programs). By design, the majority of the content is universally relevant, but optimal use of the curriculum results when it is adapted and customized to reflect local needs, assets, and cultures. Access to this online resource is free and available through the Boston Children s Hospital website. (www.childrenshospital.org/ care-coordination-curriculum). More information on care coordination is available through the National Center for Medical Home Implementation website (www.medicalhomeinfo.org). Visit the COCWD website for additional policies and membership opportunities. (www.aap.org/en-us/ about-the-aap/committees-councils- Sections/Council-on-Children-with- Disabilities/Pages/default.aspx). Reprinted from the AAP.org mental health listserv 5.13.14